20
Mylan Laboratories Limited Hyderabad In, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Lisinopril dihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-134 - Rev 01
This Chemical Type CEP, issued on September 29, 2014, remains in force until February 18, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 1120 associated with this CEP further emphasizes